T. Rowe Price Associates’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $818K | Buy |
|
|||||
|
2024
Q4 | $518K | Buy |
|
|||||
|
2024
Q3 | $562K | Buy |
|
|||||
|
2024
Q2 | $469K | Buy |
|
|||||
|
2024
Q1 | $651K | Buy |
|
|||||
|
2023
Q4 | $819K | Buy |
|
|||||
|
2023
Q3 | $701K | Sell |
|
|||||
|
2023
Q2 | $11M | Buy |
|
|||||
|
2023
Q1 | $13.1M | Buy |
|
|||||
|
2022
Q4 | $11.1M | Sell |
|
|||||
|
2022
Q3 | $13.5M | Sell |
|
|||||
|
2022
Q2 | $44.7M | Sell |
|
|||||
|
2022
Q1 | $224M | Buy |
|
|||||
|
2021
Q4 | $189M | Sell |
|
|||||
|
2021
Q3 | $544M | Buy |
|
|||||
|
2021
Q2 | $774M | Sell |
|
|||||
|
2021
Q1 | $655M | Buy |
|
|||||
|
2020
Q4 | $697M | Sell |
|
|||||
|
2020
Q3 | $636M | Sell |
|
|||||
|
2020
Q2 | $585M | Buy |
|
|||||
|
2020
Q1 | $466M | Buy |
|
|||||
|
2019
Q4 | $315M | Sell |
|
|||||
|
2019
Q3 | $293M | Buy |
|
|||||
|
2019
Q2 | $200M | Buy |
|
|||||
|
2019
Q1 | $101M | Buy |
|
|||||
|
2018
Q4 | $38.4M | Buy |
|
|||||
|
2018
Q3 | $48.2M | Buy |
|
|||||
|
2018
Q2 | $1.58M | Buy |
|
|||||
|
2018
Q1 | $1.19M | Sell |
|
|||||
|
2017
Q4 | $3.35M | Buy |
|
|||||
|
2017
Q3 | $1.09M | Sell |
|
|||||
|
2017
Q2 | $1.08M | Buy |
|
|||||
|
2017
Q1 | $1.06M | Sell |
|
|||||
|
2016
Q4 | $6.42M | Buy |
|
|||||
|
2016
Q3 | $6.54M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $13.5M | Buy |
|